Investors

Calgary Scientific's Corporate Mission is to become the Global leader in state-of-the-art Web Enablement and Mobility Enablement Software platforms. Calgary Scientific's PureWeb® platform is the foundation technology that enables this vision. The PureWeb® platform software, in combination with a family of distinctive advanced software development kits (SDKs), Calgary Scientific supports the rapid transformation of any software technology, regardless of its code base or architecture, into a fully web browser-based, high performance web technology. PureWeb can enable the refactoring of advanced applications for full workflow, feature set availability, and high performance on an array of smartphones and hand-held devices.

In addition to the PureWeb platform, Calgary Scientific also offers a portfolio of products that perform sophisticated image post-processing, including tools for 2D, MIP/MPR and 3D medical visualization, a suite of advanced cardiac assessment modules for both CT and MR, as well as whole body vessel analysis. Calgary Scientific also has proprietary intellectual property for image fusion, virtual colonoscopy and Computer Assisted Tissue Identification (CATI™). Calgary Scientific will continuously add to its product lines and intellectual property.

Calgary Scientific is currently strategically focused on making the long held industry vision for a truly virtual Healthcare I.T. environment a reality, by providing universal, web and smartphone-based access to medical images, patient data, advanced software applications, and other tools that are powerful and efficient.

Calgary Scientific is a Canadian controlled privately held corporation (CCPC), and as such is eligible for Canadian RSP-based investments.

At the current time, Calgary Scientific is not actively seeking new equity investment.  If you are interested in becoming a shareholder of Calgary Scientific in the future when the opportunity may come available, please contact us using  the investor form, and your information will be kept on file.  At such a time as investment opportunity is available, Calgary Scientific will contact you directly.  Institutional investors who wish to engage with the company in some manner should contact the CEO of Calgary Scientific, Dr. Byron Osing, on a direct basis.

Thank you for your interest in Calgary Scientific.

Dr. Byron Osing
CEO, Calgary Scientific
Inquire about investing with Calgary Scientific